Knorex Ltd （KNRX）
$1.24 +307.89%
wow.qtsky.com/stocksearch/KNRX
Kodiak Sciences Inc （KOD）
$89.92 +177.96% (MktCap: 5.65B)
wow.qtsky.com/stocksearch/KOD
Volato Group Inc （SOAR）
$0.32 +79.33% (MktCap: 17.27M)
wow.qtsky.com/stocksearch/SOAR
Lifecore Biomedical Inc （LFCR）
$6.52 +55.24% (MktCap: 246.8M)
wow.qtsky.com/stocksearch/LFCR
Enigmatig Ltd （EGG）
$4.24 +51.25% (MktCap: 118.6M)
wow.qtsky.com/stocksearch/EGG
ClearOne Inc （CLRO）
$5.1 +47.83% (MktCap: 13.64M)
wow.qtsky.com/stocksearch/CLRO
Jinxin Technology Holding Co ADR （NAMI）
$2.24 +40.88% (MktCap: 7.08M)
wow.qtsky.com/stocksearch/NAMI
Accuray Inc （ARAY）
$0.3 +39.38% (MktCap: 35.81M)
wow.qtsky.com/stocksearch/ARAY
SMJ International Holdings Inc （SMJF）
$2.17 +35.63% (MktCap: 60.12M)
wow.qtsky.com/stocksearch/SMJF
Able View Global Inc （ABLV）
$1.66 +28.08% (MktCap: 91.95M)
wow.qtsky.com/stocksearch/ABLV
========================
Knorex Ltd (KNRX)$1.24+307.89%
wow.qtsky.com/stocksearch/KNRX
Knorex (NYSE: KNRX) experienced a massive surge today, with its stock price increasing by over 300%. The primary catalyst for this significant upward volatility is the company's announcement of a strategic carve-out of its wholly-owned publisher monetization subsidiary, AscendX Media Technologies. KNOREX plans to transition AscendX into a separately capitalized entity funded by external investors, while retaining a minority equity interest.
This move is strategically important as it aims to alleviate KNOREX's financial obligation to fund AscendX's future growth, allowing the parent company to redirect capital and management focus towards its core KNOREX XPO programmatic advertising platform and KAIROS Agentic AI initiatives. AscendX has recently progressed from product development to commercial deployment with growing publisher integrations, further underscoring its potential to attract external investment.
This positive news likely triggered substantial buying interest and possibly a short squeeze. KNRX has recently faced significant challenges, including NYSE non-compliance due to a stockholders' deficit and prolonged net losses, and has been in the process of securing a $50 million share facility which implied potential dilution. The carve-out provides a clearer path to improved financial health and strategic focus, overriding these prior concerns and leading to today's dramatic price appreciation.
========================
Kodiak Sciences Inc (KOD)$89.92+177.96%
wow.qtsky.com/stocksearch/KOD
Kodiak Sciences (NASDAQ: KOD) experienced a dramatic surge in its stock price today, September 28, 2026, with shares soaring by approximately 145% to 190% in early trading following the announcement of overwhelmingly positive topline results from its pivotal Phase 3 DAYBREAK study. This trial evaluated Zenkuda (tarcocimab tedromer) and tabirafusp-ted (KSI-501) for the treatment of wet age-related macular degeneration (wAMD).
The core reason for this significant daily fluctuation is the successful achievement of primary endpoints for both drug candidates, demonstrating non-inferiority in vision gains compared to aflibercept (Regeneron's Eylea), the current standard of care, at one year. Critically, Zenkuda showcased strong durability, with 54% of patients maintaining their vision on a six-month (24-week) dosing interval using stringent treat-to-dryness criteria. This extended dosing interval represents a significant advantage over Eylea's typical eight-week regimen and is a key factor driving investor enthusiasm, as it promises reduced treatment burden for patients and potentially a competitive edge in the lucrative wAMD market. The favorable safety profile of Zenkuda, including a 0% intraocular inflammation rate, further contributed to the positive market reaction.
With these robust results, Kodiak Sciences plans to submit a multi-indication Biologics License Application (BLA) for Zenkuda to the U.S. FDA in the fourth quarter of 2026, encompassing five successful Phase 3 studies across wAMD, diabetic retinopathy, and retinal vein occlusion. This positions Zenkuda as a potential new standard of care for major retinal vascular diseases, fundamentally re-rating KOD's commercial prospects and triggering today's massive stock rally.
========================
Volato Group Inc (SOAR)$0.32+79.33%
wow.qtsky.com/stocksearch/SOAR
Volato Group, Inc. (NYSE American: SOAR) experienced a substantial positive surge today, primarily driven by a significant announcement from its newly merged AI infrastructure subsidiary, Alignment Engine. The company revealed it secured two four-year, take-or-pay orders from a large AI customer, collectively valued at $1.17 billion in aggregate contractual value. This landmark deal involves the phased deployment of AMD GPU infrastructure at Alignment Engine's Ohio campus and represents its first major customer commitment for its AI infrastructure platform. News of this "transformational commercial milestone" led to SOAR's stock soaring over 90% during premarket trading and throughout the day.
While the provided shareholder alert from early September 2026 does highlight an ongoing investigation by an M&A class action firm regarding the fairness of the Alignment Engine merger terms, particularly concerning existing Volato shareholders owning a minority interest in the combined entity, this legal concern is a background factor and not the direct cause of today's *large upward* volatility. Instead, the massive AI contract win is the dominant catalyst explaining SOAR's significant price movement today.
========================
Lifecore Biomedical Inc (LFCR)$6.52+55.24%
wow.qtsky.com/stocksearch/LFCR
Lifecore Biomedical (LFCR) experienced a significant surge in its stock price today, primarily driven by the announcement that it has entered into a definitive agreement to be acquired by an affiliate of Webster Equity Partners. The acquisition offers common shareholders $6.28 per share in cash at closing, alongside one non-tradable contingent value right (CVR) per share. This cash consideration alone represents an approximately 49.5% premium over LFCR's closing price on September 25, 2026. The total transaction, including potential CVR payments based on performance milestones, is valued at up to $663.7 million, or up to $9.67 per common share equivalent.
This merger agreement is a direct and impactful catalyst, explaining the substantial single-day upward movement, with shares trading up 55.8% to $6.54 and significantly higher volume compared to its average. While the company is also scheduled to participate in the CPHI Global Conference in October 2026, which could foster business development, this event is a secondary factor overshadowed by the definitive acquisition news as the core driver of today's volatility. High short interest in the stock (10.48% of public float as of September 15, 2026) may have amplified the price movement, but the acquisition itself is the fundamental cause.
========================
Enigmatig Ltd (EGG)$4.24+51.25%
wow.qtsky.com/stocksearch/EGG
ENIGMATIG LIMITED (NYSE American: EGG) is experiencing significant upward volatility today, despite a fundamentally weak H1 2026 earnings report that caused its revenue to halve and swung it to a net loss. This report, released on August 21, 2026, highlighted a 59.1% year-over-year drop in corporate services income and a gross margin contraction from 74.8% to 1.8%, primarily due to a strategic shift to a cost-plus billing model effective October 1, 2025.
The primary drivers for today's notable stock surge are not fresh fundamental news, but rather the stock's inherent characteristics and market dynamics. EGG is widely recognized as a "classic small-cap momentum name" known for extreme price swings and high volatility. Its valuation often reflects market sentiment and technical trading patterns more than its underlying financials, which show a "rich valuation versus tiny revenue". Following a previous crash in July 2026, where it reached a 52-week low, today's rally appears to be a technical rebound or a result of speculative trading interest. While a direct short squeeze is not confirmed for today, the general market for such volatile stocks often sees these movements.
========================
ClearOne Inc (CLRO)$5.1+47.83%
wow.qtsky.com/stocksearch/CLRO
ClearOne (CLRO) experienced a significant pre-market surge of 85.21% on September 28, 2026, primarily driven by investor optimism surrounding its transformative reverse merger with Cortigent, a subsidiary of Vivani Medical. This strategic pivot aims to transform ClearOne from an audio/video conferencing company into a medical technology firm focused on neurostimulation and brain-computer interface devices.
The stock has shown extreme volatility since the merger agreement was first announced in early July 2026, with previous spikes exceeding 98% and 150% on news of shareholder approvals and SEC filings advancing the transaction. The ongoing progress towards the targeted Q3 2026 closing of the Cortigent merger, coupled with "recent positive company developments" in regulatory filings, continues to fuel speculative interest. Despite a recent downturn in previous sessions, the market reacted strongly to renewed positive sentiment regarding the deal's progression.
Fundamental analysis of ClearOne's legacy business shows challenging financial results, including declining revenue and net losses in recent quarters, indicating that the current market excitement is predominantly linked to the high-potential, albeit high-risk, future prospects of the combined entity in the medical technology sector. Short interest in CLRO is relatively low, around 0.96% of the float, suggesting that today's sharp rise is not attributable to a short squeeze. Instead, it reflects a strong speculative response to continued merger-related developments as the company reshapes its core business.
========================
Jinxin Technology Holding Co ADR (NAMI)$2.24+40.88%
wow.qtsky.com/stocksearch/NAMI
NAMI, trading as Jinxin Technology, experienced significant volatility today, September 28, 2026, marked by a substantial intraday surge of over 38% at market open. The primary catalyst for this sharp upward movement appears to be the announcement of a strategic cooperation memorandum between its subsidiary, Namibox, and Pearson. This partnership aims to jointly shape a new global learning and education landscape leveraging AI, which has injected considerable optimism into the stock, aligning with Jinxin Technology's ongoing strategic pivot towards AI-powered smart learning hardware like the NAMI INSIGHT One.
Beyond this immediate positive news, NAMI has consistently exhibited characteristics of a highly volatile, low-priced stock, making it a favored vehicle for day traders and momentum plays. Its chart has shown rapid "squeeze" patterns followed by pullbacks, indicative of intense speculative interest and a battle between long and short positions. While the company's interim financial results for the six months ended June 30, 2026, released on September 22, 2026, revealed a drop in revenue, the narrowing of net losses offered a mixed but not entirely negative fundamental backdrop. However, the core driver for today's dramatic move is the newly announced Pearson collaboration, underscoring the market's strong reaction to strategic advancements in the burgeoning AI education sector.
========================
Accuray Inc (ARAY)$0.3+39.38%
wow.qtsky.com/stocksearch/ARAY
ARAY stock experienced a significant surge today, primarily driven by the announcement of a strategic collaboration between Accuray and Samsung NeuroLogica. The companies entered into agreements to pursue advanced volumetric imaging capabilities for Accuray's CyberKnife® System, a development unveiled at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Boston. This partnership is viewed positively as it aims to integrate Samsung NeuroLogica's mobile computed tomography (CT) and volumetric imaging expertise with Accuray's robotic radiosurgery and motion management technology. The goal is to enhance treatment efficiency and improve clinicians' ability to visualize patient anatomy during radiation therapy, potentially enabling more informed decision-making and future adaptive radiotherapy workflows.
The market reacted strongly to this news, with ARAY shares jumping over 42% in premarket trading and continuing to climb, reaching gains of nearly 60% during Monday's regular session. While this collaboration signals a promising innovation for Accuray's core product, it is important to note that no commercial product has been announced yet, and future developments are subject to ongoing evaluation and regulatory requirements. The substantial price movement was likely amplified by the stock's pre-existing bearish trend and low valuation (trading at $0.22, significantly below its 200-day EMA of $0.50 as of September 28, 2026), coupled with elevated short interest (8.31 days to cover as of August 31, 2026). This combination suggests that the positive news might have triggered a short squeeze, forcing short sellers to cover their positions amidst high trading volume, thus exacerbating the upward price pressure.
========================
SMJ International Holdings Inc (SMJF)$2.17+35.63%
wow.qtsky.com/stocksearch/SMJF
The significant volatility in SMJF is primarily driven by recent corporate governance changes, exacerbated by prior unexplained "unusual market activity" and high short interest in an already high-risk, micro-cap stock.
Specifically, on September 15, 2026, shareholders approved amendments to the company's governing documents, notably reshaping Class B voting power by removing certain automatic conversion triggers for Class B (super-voting) shares to Class A shares. This move solidifies the control of Class B shareholders, who possess ten votes per share compared to Class A's one vote. Such a concentration of power can be perceived negatively by minority shareholders, leading to a re-evaluation of governance risk and fostering selling pressure.
This governance shift followed an alarming event on August 27, 2026, when SMJF experienced a drastic 87% single-day decline, which the company later attributed to "unusual market action" without identifying any specific cause or material nonpublic information. This unexplained collapse severely eroded investor confidence and likely set the stage for heightened sensitivity to subsequent news.
Furthermore, short interest in SMJF surged by 1079.1% to 464.7 thousand shares, representing 17.21% of its float as of September 26, 2026. This substantial bearish positioning indicates significant market skepticism and can amplify price swings, potentially leading to short squeezes or accelerated declines. Compounding these factors are the company's recent shift to a net loss in FY2026 and its inherent characteristics as a micro-cap stock with a history of extreme volatility, limited financial data, and concerns over debt coverage.
========================
Able View Global Inc (ABLV)$1.66+28.08%
wow.qtsky.com/stocksearch/ABLV
Able View Global (ABLV) experienced significant fluctuation recently, primarily driven by its registered share sale which closed on September 17, 2026. The company issued 5,830,904 Class B ordinary shares to a single institutional investor at a price of $0.343 per share, raising $2 million in gross proceeds.
The immediate and core reason for the stock's volatility stems from this offering's dilutive nature. Selling new shares at $0.343, significantly below the stock's recent trading range (e.g., closing at $0.9699 on September 23, 2026, or trading near $1.30 on September 26, 2026), typically signals urgent capital needs and creates downward pressure due to dilution for existing shareholders. While the capital infusion for working capital and general corporate purposes provides essential liquidity, ensuring short-term operational viability and potentially aiding in regaining Nasdaq minimum bid price compliance, the heavily discounted price indicates a distressed financing scenario.
The market is currently digesting this dilutive event, leading to varied reactions. While some investors may view the capital raise as a positive step towards stability and Nasdaq listing compliance (the company has a history of minimum bid price deficiency notices), others are reacting to the substantial dilution and the implied valuation at which new capital was brought in. This divergence in sentiment, coupled with the inherent volatility of such micro-cap stocks, accounts for the observed significant fluctuations.
========================
For daily analysis of top US stock market losers visit:
https://bigmovewhy.qtsky.com/us-stocks
--------------------------------------------------------
BigMoveWhy-BMW is powered by WOW!StockSearch
Tech Development by QTsky (Build your own tools)
https://wow.qtsky.com
